Pamela Foulds
Direttore Tecnico/Scientifico/R&S presso FREELINE THERAPEUTICS HOLDINGS PLC
Profilo
Pamela Foulds is currently the Chief Medical Officer at Auregen Biotherapeutics SA and Freeline Therapeutics Holdings Plc.
Previously, she held the position of Chief Medical Officer at Aegerion Pharmaceuticals, Inc. and Auregen Biotherapeutics, Inc. Foulds received her undergraduate degree from Georgetown University and her doctorate from Georgetown University School of Medicine.
Posizioni attive di Pamela Foulds
| Società | Posizione | Inizio |
|---|---|---|
| FREELINE THERAPEUTICS HOLDINGS PLC | Direttore Tecnico/Scientifico/R&S | 01/11/2021 |
Auregen Biotherapeutics SA
 Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Pamela Foulds
| Società | Posizione | Fine |
|---|---|---|
| AEGERION PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Auregen Biotherapeutics, Inc.
 Auregen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auregen Biotherapeutics, Inc. provides biotechnology services. The CEO of the American company is Richard John Davies. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Pamela Foulds
| Georgetown University | Undergraduate Degree |
| Georgetown University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Auregen Biotherapeutics, Inc.
Auregen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auregen Biotherapeutics, Inc. provides biotechnology services. The CEO of the American company is Richard John Davies. | Commercial Services |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Auregen Biotherapeutics SA
Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland. | Technology Services |
- Borsa valori
- Insiders
- Pamela Foulds